Cochrane · systematic review · CD000279
Strategies for detecting colon cancer in patients with inflammatory bowel disease
Bye, WA, Nguyen, TM, Parker, CE, et al. · Cochrane Database of Systematic Reviews · 2017 · Cochrane Library
GutAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
4
current version
GRADE rated
4
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 4 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Surveillance compared to non surveillance for detecting colon cancer in patients with inflammatory bowel disease
Population: detecting colon cancer in patients with inflammatory bowel disease
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Cancer detection Surveillance vs non surveillance | OR 0.58 [0.42, 0.8] | 3 studies · 7151 participants | Very low Downgraded: imprecision, inconsistency |
Death from colorectal cancer Surveillance vs non surveillance | OR 0.36 [0.19, 0.69] | 4 studies · 530 participants | Very low Downgraded: imprecision, inconsistency |
Cancer stage‐ Duke A or B Surveillance vs non surveillance | OR 5.4 [1.51, 19.3] | 2 studies · 227 participants | Very low Downgraded: imprecision, inconsistency |
Cancer stage‐ Duke C or D Surveillance vs non surveillance | OR 0.46 [0.08, 2.51] | 2 studies · 227 participants | Very low Downgraded: imprecision, inconsistency |